<bill session="117" type="h" number="6282" updated="2022-12-30T03:04:01Z">
  <state datetime="2021-12-14">REFERRED</state>
  <status>
    <introduced datetime="2021-12-14"/>
  </status>
  <introduced datetime="2021-12-14"/>
  <titles>
    <title type="display">COVID&#226;&#8364;&#8220;19 Vaccine Accountability Act</title>
    <title type="short" as="introduced">COVID&#226;&#8364;&#8220;19 Vaccine Accountability Act</title>
    <title type="official" as="introduced">To amend title III of the Public Health Service Act to eliminate immunity for manufacturers of COVID-19 vaccines, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="P000605"/>
  <cosponsors>
    <cosponsor bioguide_id="G000552" joined="2021-12-14"/>
  </cosponsors>
  <actions>
    <action datetime="2021-12-14">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-12-14" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2021-12-15">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Cardiovascular and respiratory health"/>
    <term name="Civil actions and liability"/>
    <term name="Emergency medical services and trauma care"/>
    <term name="Government liability"/>
    <term name="Immunology and vaccination"/>
    <term name="Infectious and parasitic diseases"/>
    <term name="Manufacturing"/>
  </subjects>
  <amendments/>
  <summary date="2022-03-28T16:10:54Z" status="Introduced in House">COVID-19 Vaccine Accountability Act

This bill excludes manufacturers of a mandated COVID-19 vaccine from certain liability protections that apply to manufacturers of medical countermeasures (i.e., medical products that may be used to treat, prevent, or diagnose conditions associated with emerging infectious diseases or chemical, biological, radiological, or nuclear agents). It also retroactively limits to $10,000 the liability of the United States for a death or injury caused by a COVID-19 vaccine administered on or after January 1, 2020.</summary>
</bill>
